Tone mix
Week by week 52 weeks
Share of ABBVIE INC.'s 1,266 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Mar 2, 2026 · tone +79Equities Research Analysts' Upgrades for February 28th (AAOI, ABBV, ABR, ACIU, ACMR, ADMA, ADTN, AHT, AIT, ALTG)+46
- Week of Jun 8, 2026 · tone -1Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225-37
- Week of Jan 12, 2026 · tone +55Trump administration strikes deal with AbbVie to cut costs of certain drugs+34
- Week of Feb 23, 2026 · tone +60Barclays Initiates AbbVie (ABBV) with Overweight Rating on Growth Potential+33
- Week of Sep 28, 2026 · tone +56AbbVie Stock: Buy, Sell, or Hold in October?+27
- Week of Jul 27, 2026 · tone +2AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?-26
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about ABBVIE INC. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 22 | +33 |
| Last 30 sessions | 135 | +41 |
| Last 90 sessions | 370 | +29 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- markets.financialcontent.com · 1 outletFinancialContent - AbbVie (ABBV) reports earnings tomorrow: what to expectNeutral
- www.rttnews.com · 1 outletAbbVie's BOTOX Cosmetic Day Returns November 18 With Special OffersNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FinancialContent - AbbVie (ABBV) reports earnings tomorrow: what to expect | markets.financialcontent.com | 1 | Neutral |
| AbbVie's BOTOX Cosmetic Day Returns November 18 With Special Offers | www.rttnews.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
2 headlines, average tone +76: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.cnbc.com · 1 outletWhy AbbVie's next wave of blockbuster drugs has me buying the stockPositive
- www.rttnews.com · 1 outletAbbVie Submits FDA Application For Etentamig In Multiple MyelomaPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Why AbbVie's next wave of blockbuster drugs has me buying the stock | www.cnbc.com | 1 | Positive |
| AbbVie Submits FDA Application For Etentamig In Multiple Myeloma | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
3 headlines, average tone +59: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.rttnews.com · 2 outletsAbbVie Gains FDA Approval For Subcutaneous Induction Of SKYRIZI In Crohn's DiseasePositive
- www.aol.com · 2 outletsAbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?Positive
- www.tickerreport.com · 1 outlet6,150 AbbVie Inc. $ABBV Shares Sold by Yousif Capital Management LLCNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| AbbVie Gains FDA Approval For Subcutaneous Induction Of SKYRIZI In Crohn's Disease | www.rttnews.com | 2 | Positive |
| AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's? | www.aol.com | 2 | Positive |
| 6,150 AbbVie Inc. $ABBV Shares Sold by Yousif Capital Management LLC | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
5 headlines, average tone +40: 2 positive, 3 neutral and 0 negative. Showing all 5.
- www.aol.com · 3 outletsWhat Higher Interest Rates Mean for Dividend Stocks Like AbbVie and PfizerNeutral
- www.fool.com · 2 outletsGreat News for AbbVie Stock Investors | The Motley FoolPositive
- www.aol.com · 1 outletGreat News for AbbVie Stock InvestorsPositive
- www.themarketsdaily.com · 1 outletAbbVie Inc. $ABBV Stock Acquired by Crescent Grove Advisors LLCNeutral
- www.themarketsdaily.com · 1 outletAbbVie Inc. $ABBV Stock: Lmcg Investments LLC Decreases StakeNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer | www.aol.com | 3 | Neutral |
| Great News for AbbVie Stock Investors | The Motley Fool | www.fool.com | 2 | Positive |
| Great News for AbbVie Stock Investors | www.aol.com | 1 | Positive |
| AbbVie Inc. $ABBV Stock Acquired by Crescent Grove Advisors LLC | www.themarketsdaily.com | 1 | Neutral |
| AbbVie Inc. $ABBV Stock: Lmcg Investments LLC Decreases Stake | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
7 headlines, average tone +14: 2 positive, 4 neutral and 1 negative. Showing all 7.
- www.fool.com · 2 outletsAbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?Neutral
- www.rttnews.com · 1 outletAbbVie Highlights New HArmonyCa Results In Patients Using GLP-1 Weight-Loss DrugsPositive
- www.insidermonkey.com · 1 outletAbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?Positive
- www.rttnews.com · 1 outletAbbVie's HArmonyCa Shows Midface Improvement In GLP-1 Patient Analysis; Stock DownNegative
- www.dailypolitical.com · 1 outletSowell Financial Services LLC Buys 3,985 Shares of AbbVie Inc. $ABBVNeutral
- www.dailypolitical.com · 1 outletComparing TScan Therapeutics (NASDAQ:TCRX) & AbbVie (NYSE:ABBV)Neutral
- www.tickerreport.com · 1 outletAbbVie (NYSE:ABBV) & TScan Therapeutics (NASDAQ:TCRX) Financial ComparisonNeutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue? | www.fool.com | 2 | Neutral |
| AbbVie Highlights New HArmonyCa Results In Patients Using GLP-1 Weight-Loss Drugs | www.rttnews.com | 1 | Positive |
| AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story? | www.insidermonkey.com | 1 | Positive |
| AbbVie's HArmonyCa Shows Midface Improvement In GLP-1 Patient Analysis; Stock Down | www.rttnews.com | 1 | Negative |
| Sowell Financial Services LLC Buys 3,985 Shares of AbbVie Inc. $ABBV | www.dailypolitical.com | 1 | Neutral |
| Comparing TScan Therapeutics (NASDAQ:TCRX) & AbbVie (NYSE:ABBV) | www.dailypolitical.com | 1 | Neutral |
| AbbVie (NYSE:ABBV) & TScan Therapeutics (NASDAQ:TCRX) Financial Comparison | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about ABBVIE INC., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.